Company / Total Assets
Zenas BioPharma, Inc. Total Assets History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$383.6M
FY2025
5-year range
$68.2M / $383.6M
FY2023-FY2025
Trend
+3.7%
vs FY2024
Sector context
#162 of 214
Health Care
What the data says
Zenas BioPharma, Inc.'s total assets of $384M is lower than 76% of companies in the Health Care sector (FY2025). Improved from $68M to $384M over the past 2 years.
Based on SEC 10-K filings.
$384M in FY2025.
Improved from $68M to $384M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 24% in Health CareTop 76% of 214This company $383.6M Sector average $7.5B
▼
-94.9% below sector average
Key checks
Key Insights
- In FY2025, total assets increased 3.7% year-over-year.
- Ranks #162 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.51 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $383.6M | +3.7% |
| FY2024 | $370.0M | +442.6% |
| FY2023 | $68.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026